BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35063379)

  • 1. Prognostic Value of
    Uusitalo V; Suomalainen O; Loimaala A; Mätzke S; Heliö T
    Heart Lung Circ; 2022 May; 31(5):629-637. PubMed ID: 35063379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of incidental suspected transthyretin amyloidosis on routine bone scintigraphy.
    Suomalainen O; Pilv J; Loimaala A; Mätzke S; Heliö T; Uusitalo V
    J Nucl Cardiol; 2022 Jun; 29(3):1021-1029. PubMed ID: 33094472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
    Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
    Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association of Cardiac Biomarkers, the Intensity of Tc99 Pyrophosphate Uptake, and Survival in Patients Evaluated for Transthyretin Cardiac Amyloidosis in the Early Therapeutics Era.
    Martyn T; Saef J; Hussain M; Ives L; Kiang A; Estep JD; Collier P; Starling RC; Cremer PC; Tang WHW; Hanna M; Jaber WA
    J Card Fail; 2022 Oct; 28(10):1509-1518. PubMed ID: 35843490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid.
    Hutt DF; Fontana M; Burniston M; Quigley AM; Petrie A; Ross JC; Page J; Martinez-Naharro A; Wechalekar AD; Lachmann HJ; Quarta CC; Rezk T; Mahmood S; Sachchithanantham S; Youngstein T; Whelan CJ; Lane T; Gilbertson JA; Rowczenio D; Hawkins PN; Gillmore JD
    Eur Heart J Cardiovasc Imaging; 2017 Dec; 18(12):1344-1350. PubMed ID: 28159995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis.
    Cappelli F; Gallini C; Di Mario C; Costanzo EN; Vaggelli L; Tutino F; Ciaccio A; Bartolini S; Angelotti P; Frusconi S; Farsetti S; Vergaro G; Giorgetti A; Marzullo P; Genovesi D; Emdin M; Perfetto F
    J Nucl Cardiol; 2019 Apr; 26(2):497-504. PubMed ID: 28537040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.
    Galat A; Rosso J; Guellich A; Van Der Gucht A; Rappeneau S; Bodez D; Guendouz S; Tissot CM; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Itti E; Meignan M; Damy T
    Amyloid; 2015; 22(4):210-20. PubMed ID: 26465835
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Tahara N; Lairez O; Endo J; Okada A; Ueda M; Ishii T; Kitano Y; Lee HE; Russo E; Kubo T
    ESC Heart Fail; 2022 Feb; 9(1):251-262. PubMed ID: 34841715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.
    Castano A; Haq M; Narotsky DL; Goldsmith J; Weinberg RL; Morgenstern R; Pozniakoff T; Ruberg FL; Miller EJ; Berk JL; Dispenzieri A; Grogan M; Johnson G; Bokhari S; Maurer MS
    JAMA Cardiol; 2016 Nov; 1(8):880-889. PubMed ID: 27557400
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Khor YM; Cuddy SAM; Singh V; Falk RH; Di Carli MF; Dorbala S
    Radiology; 2023 Feb; 306(2):e221082. PubMed ID: 36537896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of myocardial
    Pradel S; Brun S; Victor G; Pascal P; Fournier P; Ribes D; Lavie-Badie Y; Galinier M; Carrié D; Berry I; Lairez O;
    J Nucl Cardiol; 2020 Feb; 27(1):96-105. PubMed ID: 29881913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-phase myocardial uptake intensity of
    Abulizi M; Cottereau AS; Guellich A; Vandeventer S; Galat A; Van Der Gucht A; Plante-Bordeneuve V; Dubois-Randé JL; Bodez D; Rosso J; Damy T; Itti E
    J Nucl Cardiol; 2018 Feb; 25(1):217-222. PubMed ID: 27804073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional Variation in Technetium Pyrophosphate Uptake in Transthyretin Cardiac Amyloidosis and Impact on Mortality.
    Sperry BW; Vranian MN; Tower-Rader A; Hachamovitch R; Hanna M; Brunken R; Phelan D; Cerqueira MD; Jaber WA
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 1):234-242. PubMed ID: 28917675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Utility of
    Moore PT; Burrage MK; Mackenzie E; Law WP; Korczyk D; Mollee P
    Heart Lung Circ; 2017 Nov; 26(11):1183-1190. PubMed ID: 28256403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac morbidity and the cause of death in elderly patients with prostate cancer and incidental cardiac uptake on bone scintigraphy.
    Juntunen E; Suomalainen O; Mätzke S; Heliö T; Loimaala A; Uusitalo V
    Clin Physiol Funct Imaging; 2024 Jan; 44(1):49-55. PubMed ID: 37421321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.
    Bokhari S; Castaño A; Pozniakoff T; Deslisle S; Latif F; Maurer MS
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):195-201. PubMed ID: 23400849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic contribution of DPD scintigraphy in transthyretin V30M cardiac amyloidosis.
    Azevedo Coutinho MC; Cortez-Dias N; Cantinho G; Gonçalves S; Cunha N; Rodrigues T; Santos L; Conceição I; Agostinho J; Pinto FJ
    Amyloid; 2024 Mar; 31(1):32-41. PubMed ID: 37493395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging cardiac innervation in hereditary transthyretin (ATTRm) amyloidosis: A marker for neuropathy or cardiomyopathy in case of heart failure?
    Jonker DL; Hazenberg BPC; Nienhuis HLA; Slart RHJA; Glaudemans AWJM; Noordzij W
    J Nucl Cardiol; 2020 Oct; 27(5):1774-1784. PubMed ID: 30374850
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Flaherty KR; Morgenstern R; Pozniakoff T; DeLuca A; Castano A; Maurer MS; Bokhari S
    J Nucl Cardiol; 2020 Apr; 27(2):371-380. PubMed ID: 31463816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Native T1 and Extracellular Volume in Transthyretin Amyloidosis.
    Martinez-Naharro A; Kotecha T; Norrington K; Boldrini M; Rezk T; Quarta C; Treibel TA; Whelan CJ; Knight DS; Kellman P; Ruberg FL; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2019 May; 12(5):810-819. PubMed ID: 29550324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.